These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 15268676)
21. Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle. Abadie J; Blouin V; Guigand L; Wyers M; Cherel Y Gene Ther; 2002 Aug; 9(15):1037-43. PubMed ID: 12101435 [TBL] [Abstract][Full Text] [Related]
22. Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases. Berns KI; Srivastava A Gastroenterol Clin North Am; 2019 Jun; 48(2):319-330. PubMed ID: 31046978 [TBL] [Abstract][Full Text] [Related]
23. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer. Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746 [TBL] [Abstract][Full Text] [Related]
24. Strategies to optimize capsid protein expression and single-stranded DNA formation of adeno-associated virus in Saccharomyces cerevisiae. Galli A; Della Latta V; Bologna C; Pucciarelli D; Cipriani F; Backovic A; Cervelli T J Appl Microbiol; 2017 Aug; 123(2):414-428. PubMed ID: 28609559 [TBL] [Abstract][Full Text] [Related]
25. Rate limiting steps of AAV transduction and implications for human gene therapy. Sanlioglu S; Monick MM; Luleci G; Hunninghake GW; Engelhardt JF Curr Gene Ther; 2001 Jul; 1(2):137-47. PubMed ID: 12108951 [TBL] [Abstract][Full Text] [Related]
26. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. McCarty DM; Fu H; Monahan PE; Toulson CE; Naik P; Samulski RJ Gene Ther; 2003 Dec; 10(26):2112-8. PubMed ID: 14625565 [TBL] [Abstract][Full Text] [Related]
27. Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Wang J; Xie J; Lu H; Chen L; Hauck B; Samulski RJ; Xiao W Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13104-9. PubMed ID: 17664425 [TBL] [Abstract][Full Text] [Related]
28. Recombinant adeno-associated virus as delivery vector for gene therapy--a review. Lu Y Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701 [TBL] [Abstract][Full Text] [Related]
30. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Wang Z; Ma HI; Li J; Sun L; Zhang J; Xiao X Gene Ther; 2003 Dec; 10(26):2105-11. PubMed ID: 14625564 [TBL] [Abstract][Full Text] [Related]
31. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo. Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512 [TBL] [Abstract][Full Text] [Related]
32. Tissue and cell-type-specific transduction using rAAV vectors in lung diseases. Kochergin-Nikitsky K; Belova L; Lavrov A; Smirnikhina S J Mol Med (Berl); 2021 Aug; 99(8):1057-1071. PubMed ID: 34021360 [TBL] [Abstract][Full Text] [Related]
33. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy. Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456 [TBL] [Abstract][Full Text] [Related]
34. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Blankinship MJ; Gregorevic P; Allen JM; Harper SQ; Harper H; Halbert CL; Miller AD; Chamberlain JS Mol Ther; 2004 Oct; 10(4):671-8. PubMed ID: 15451451 [TBL] [Abstract][Full Text] [Related]
35. Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors. Chen S; Kapturczak M; Loiler SA; Zolotukhin S; Glushakova OY; Madsen KM; Samulski RJ; Hauswirth WW; Campbell-Thompson M; Berns KI; Flotte TR; Atkinson MA; Tisher CC; Agarwal A Hum Gene Ther; 2005 Feb; 16(2):235-47. PubMed ID: 15761263 [TBL] [Abstract][Full Text] [Related]
36. [Capsid assembly and DNA encapsidation of adeno-associated virus]. Wang Q; Lü Y; Li Z; Diao Y; Xu R Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):531-8. PubMed ID: 21847986 [TBL] [Abstract][Full Text] [Related]
37. Gene therapy using adeno-associated virus vectors. Daya S; Berns KI Clin Microbiol Rev; 2008 Oct; 21(4):583-93. PubMed ID: 18854481 [TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]